Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ilari

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical and Pediatric Oncology|December 18, 2001
Sternal lesions in childrenA Donfrancesco, I Ilari, C Miano
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 4, 2000
Activated protein C resistance is a risk factor for central retinal vein occlusionR Marcucci, L Bertini, A A Liotta, et al.
Oncogene|September 21, 1995
Resistance to Fas-mediated apoptosis in human hepatoma cellsG Natoli, A Ianni, A Costanzo, et al.
Thrombosis Research|April 15, 1996
Hemostatic abnormalities in inflammatory bowel diseaseE Chiarantini, R Valanzano, A A Liotta, et al.
Thrombosis Research|October 23, 1997
Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgeryE Chiarantini, R Valanzano, A A Liotta, et al.
The British Journal of Ophthalmology|June 27, 2009
Metastatic retinoblastoma: single institution experience over two decadesR Cozza, M A De Ioris, I Ilari, et al.
Minerva Cardioangiologica|February 12, 2000
[Lp(a): a new risk factor for deep venous thrombosis?]A Alessandrello Liotta, R Marcucci, W Bialek, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Minerva Cardioangiologica|February 12, 2000
[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs]A Rogolino, A Farsi, T Brunelli, et al.
Minerva Cardioangiologica|February 12, 2000
[Risk factors of cardiovascular pathology after kidney transplantation. New perspectives]R Marcucci, M Zanazzi, E Bertoni, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical and Pediatric Oncology|December 18, 2001
Sternal lesions in childrenA Donfrancesco, I Ilari, C Miano
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 4, 2000
Activated protein C resistance is a risk factor for central retinal vein occlusionR Marcucci, L Bertini, A A Liotta, et al.
Oncogene|September 21, 1995
Resistance to Fas-mediated apoptosis in human hepatoma cellsG Natoli, A Ianni, A Costanzo, et al.
Thrombosis Research|April 15, 1996
Hemostatic abnormalities in inflammatory bowel diseaseE Chiarantini, R Valanzano, A A Liotta, et al.
Thrombosis Research|October 23, 1997
Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgeryE Chiarantini, R Valanzano, A A Liotta, et al.
The British Journal of Ophthalmology|June 27, 2009
Metastatic retinoblastoma: single institution experience over two decadesR Cozza, M A De Ioris, I Ilari, et al.
Minerva Cardioangiologica|February 12, 2000
[Lp(a): a new risk factor for deep venous thrombosis?]A Alessandrello Liotta, R Marcucci, W Bialek, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Minerva Cardioangiologica|February 12, 2000
[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs]A Rogolino, A Farsi, T Brunelli, et al.
Minerva Cardioangiologica|February 12, 2000
[Risk factors of cardiovascular pathology after kidney transplantation. New perspectives]R Marcucci, M Zanazzi, E Bertoni, et al.
Pageof 2